XASXAC8
Market cap10mUSD
Aug 31, Last price
0.04AUD
Name
Auscann Group Holdings Ltd
Chart & Performance
Profile
AusCann Group Holdings Ltd does not have significant operations. Previously, it was engaged in the researches, develops, and commercializes various cannabinoid-derived therapeutic products. The company is headquartered in West Perth, Australia.
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | 2016‑06 | 2015‑06 | |
Income | |||||||||
Revenues | 1,514 -8.01% | ||||||||
Cost of revenue | 2,201 | 5,798 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | (2,201) | (4,284) | |||||||
NOPBT Margin | |||||||||
Operating Taxes | 25 | 21,458 | |||||||
Tax Rate | |||||||||
NOPAT | (2,226) | (25,742) | |||||||
Net income | (10,816) -58.97% | (26,358) 205.02% | |||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
Debt | |||||||||
Debt current | 40 | ||||||||
Long-term debt | 40 | ||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | (7,344) | (12,837) | |||||||
Cash flow | |||||||||
Cash from operating activities | (3,328) | (2,831) | |||||||
CAPEX | (85) | ||||||||
Cash from investing activities | 4,657 | (5,085) | |||||||
Cash from financing activities | (36) | (48) | |||||||
FCF | 20 | (26,334) | |||||||
Balance | |||||||||
Cash | 7,298 | 5,717 | |||||||
Long term investments | 47 | 7,200 | |||||||
Excess cash | 7,344 | 12,841 | |||||||
Stockholders' equity | 17,124 | 18,154 | |||||||
Invested Capital | 9,780 | 5,353 | |||||||
ROIC | |||||||||
ROCE | |||||||||
EV | |||||||||
Common stock shares outstanding | 440,547 | 440,547 | |||||||
Price | 0.04 -62.63% | ||||||||
Market cap | 16,300 -53.26% | ||||||||
EV | 3,463 | ||||||||
EBITDA | (2,156) | (2,445) | |||||||
EV/EBITDA | |||||||||
Interest | 30 | ||||||||
Interest/NOPBT |